Check out our most popular compounded medications! Get Started
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution is a sterile liquid formulation specifically designed for ocular use. It is dispensed in an eye dropper bottle for precise and controlled application, delivering medication directly to the eyes. This formulation is used to treat a range of ophthalmic conditions, including inflammation, allergic reactions, and post-surgical swelling. By reducing inflammation and suppressing immune responses, it provides relief from symptoms and promotes healing in affected ocular tissues.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution is a sterile liquid formulation meticulously crafted for ocular use, ensuring both safety and efficacy in treating a variety of eye conditions. This formulation is dispensed in an eye dropper bottle, which allows for precise and controlled application, making it convenient for patients to administer the medication themselves. The solution is designed to deliver medication directly to the eyes, providing targeted treatment for inflammation and other ophthalmic conditions. Methylprednisolone, a potent corticosteroid, works by reducing inflammation and suppressing the immune response, which can be beneficial in treating conditions such as allergic conjunctivitis, uveitis, and other inflammatory eye disorders.
For patients, this formulation offers a non-invasive treatment option that can be easily incorporated into daily routines. The eye dropper bottle ensures that the correct dosage is administered, minimizing the risk of overuse or underuse. Patients should follow the prescribed dosage and frequency as directed by their healthcare provider to achieve optimal results. It is important to note that while this medication can significantly alleviate symptoms of inflammation, it should be used under the guidance of a healthcare professional to avoid potential side effects associated with corticosteroid use, such as increased intraocular pressure or cataract formation.
For prescribers, Methylprednisolone Sodium Succinate 1% Ophthalmic Solution offers a reliable option for managing inflammatory eye conditions. Its formulation as an ophthalmic solution allows for direct application to the affected area, ensuring rapid onset of action. Prescribers should consider the patient's overall health condition, potential contraindications, and the severity of the eye condition when recommending this treatment. Regular monitoring of the patient's response to the medication is advised to adjust the treatment plan as necessary and to mitigate any adverse effects.
Both patients and prescribers should be aware of the importance of maintaining sterility when using this ophthalmic solution. Patients should be instructed on proper application techniques to avoid contamination of the dropper tip and the solution itself. If you have any questions or require further information about Methylprednisolone Sodium Succinate 1% Ophthalmic Solution, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation.
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution is a potent corticosteroid formulation used to treat various inflammatory and allergic conditions of the eye.
Patients using this ophthalmic solution should be cautious when concurrently using other medications that may potentiate systemic corticosteroid effects. Although the systemic absorption of methylprednisolone from ophthalmic use is minimal, interactions can still occur, particularly with prolonged use or in patients with compromised ocular barriers. Concomitant use of other corticosteroids, whether systemic or topical, can increase the risk of systemic side effects such as immunosuppression, increased intraocular pressure, and potential for cataract formation. It is advisable to monitor intraocular pressure regularly if the patient is using multiple corticosteroid formulations.
Nonsteroidal anti-inflammatory drugs (NSAIDs) used concurrently with methylprednisolone ophthalmic solution may increase the risk of corneal complications. Patients should be advised to report any signs of corneal thinning or ulceration promptly. Additionally, the use of anticholinergic drugs may exacerbate the risk of increased intraocular pressure, and caution is advised when these are prescribed together.
Patients on medications that affect the cytochrome P450 enzyme system, particularly CYP3A4 inhibitors such as ketoconazole, itraconazole, or certain protease inhibitors, may experience increased systemic exposure to methylprednisolone, potentially leading to enhanced systemic corticosteroid effects. Conversely, CYP3A4 inducers like rifampin or phenytoin may reduce the efficacy of the ophthalmic corticosteroid by increasing its metabolism.
For patients with a history of ocular herpes simplex, the use of corticosteroids can exacerbate viral replication and should be used with caution. It is essential to monitor for signs of viral reactivation and to consider antiviral prophylaxis if necessary. Additionally, patients with a history of glaucoma should be closely monitored due to the potential for corticosteroids to increase intraocular pressure.
Patients and prescribers should be aware of these potential interactions and monitor for any adverse effects or changes in efficacy. It is important to maintain open communication with healthcare providers and report any unusual symptoms or concerns promptly. If you have any questions or require further information, please reach out to us at Bayview Pharmacy. We are here to assist you with any inquiries regarding this formulation or its use in treating ophthalmic conditions.
Methylprednisolone Sodium Succinate 1% Ophthalmic Solution is a sterile liquid formulation meticulously crafted for ocular use, ensuring both safety and efficacy in treating a variety of eye conditions. This solution is dispensed in an eye dropper bottle, allowing for precise and controlled application directly to the eyes. The formulation is designed to deliver medication effectively to the ocular surface, providing relief and treatment for inflammatory and allergic conditions affecting the eyes.
The active ingredient, Methylprednisolone Sodium Succinate, is a potent corticosteroid that works by modulating the body's immune response to reduce inflammation. When applied topically to the eye, it penetrates the ocular tissues to exert its anti-inflammatory effects, thereby alleviating symptoms such as redness, swelling, and irritation.
For patients, the use of this ophthalmic solution can lead to significant improvement in comfort and visual acuity by reducing the inflammatory processes that can impair vision and cause discomfort. The formulation is designed to be gentle on the eyes, minimizing potential irritation while maximizing therapeutic benefits. Patients are advised to follow the prescribed dosage and application instructions carefully to achieve optimal results and minimize the risk of side effects.
For prescribers, Methylprednisolone Sodium Succinate 1% Ophthalmic Solution offers a targeted approach to managing ocular inflammation. Its formulation ensures that the active ingredient is delivered efficiently to the site of action, providing rapid relief from symptoms. The solution's sterile nature and precise delivery system make it a reliable choice for treating sensitive eye conditions, ensuring that the medication is applied in a controlled manner to avoid contamination and ensure patient safety.
As with any medication, it is important for both patients and prescribers to be aware of potential side effects and contraindications. Patients should be monitored for any adverse reactions, and the use of the solution should be adjusted or discontinued if necessary. If you have any questions or require further information about Methylprednisolone Sodium Succinate 1% Ophthalmic Solution, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have.
This ophthalmic solution is used to treat a range of ocular conditions, including inflammation, allergies, and certain types of eye injuries. Its anti-inflammatory properties help alleviate symptoms such as redness, swelling, and irritation in the eyes.
Gently pull down your lower eyelid to create a small pocket. Tilt your head back and squeeze one drop into the pocket of your lower eyelid, being careful not to touch the dropper tip to your eye or any other surface. Close your eyes for a few moments to allow the solution to spread evenly.
The frequency of use will depend on the condition being treated and your doctor's instructions. Always follow the prescribed dosage and schedule provided by your healthcare provider.
Possible side effects include mild stinging or burning upon application, increased eye pressure, or a temporary blurring of vision. If you experience significant discomfort or changes in vision, contact your healthcare provider immediately.
It's recommended to remove contact lenses before applying the eye drops. Wait at least 15 minutes after using the solution to reinsert your lenses. Consult your healthcare provider for personal advice.
Store the solution in a cool, dry place away from direct light. Keep the bottle tightly closed when not in use, and ensure it is out of reach of children and pets.
Yes, this ophthalmic solution is a prescription medication and should only be used under the guidance and supervision of a licensed healthcare provider.
Avoid touching the dropper tip to any surface, including your eyes, to prevent contamination. If you experience persistent pain, irritation, or vision changes, discontinue use and consult your healthcare provider.
This solution should only be used in children if prescribed by a healthcare provider who will determine the appropriate dosage and frequency based on the child's specific condition.
If you miss a dose, use it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your normal dosing schedule. Do not use a double dose to make up for the missed one.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Instill 1 drop into affected eye(s)
